Should the EU exempt critical sectors, like pharmaceuticals and semiconductors, from its retaliatory tariffs on U.S. goods?

As of April 2025, the EU’s tariff countermeasures hit U.S. imports like bourbon and steel but spared pharmaceuticals and semiconductors to avoid disrupting vital supply chains. With U.S. tariffs threatening €85 billion in EU exports, including €46.3 billion in autos, the bloc weighs whether exemptions safeguard its economy or weaken its stance against Washington.